55111-617 : Eszopiclone 3 mg Oral Tablet, Coated


NDC: 55111-617
Labeler: Dr. Reddy's Laboratories Limited
Product Type: Human Prescription Drug
Drug Name:  Eszopiclone
Dosage Form: Oral Tablet, Coated
Application #: ANDA091024
Rev. Date: 
CSA Schedule: CIV (US) [1]


[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: RDY;617
Shapes:  Round
Colors:  Blue
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 55111-617-01: 100 TABLET, COATED IN 1 BOTTLE (55111‑617‑01)
  • 55111-617-05: 500 TABLET, COATED IN 1 BOTTLE (55111‑617‑05)
  • 55111-617-09: 9 BLISTER PACK IN 1 CARTON (55111‑617‑09) > 10 TABLET, COATED IN 1 BLISTER PACK (55111‑617‑79)
  • 55111-617-30: 30 TABLET, COATED IN 1 BOTTLE (55111‑617‑30)
  • 55111-617-90: 90 TABLET, COATED IN 1 BOTTLE (55111‑617‑90)

Active Ingredients:

  • Eszopiclone

Dosage Strength:

  • 3 mg

Inactive Ingredients:

  • Croscarmellose Sodium
  • Hypromelloses
  • Lactose Monohydrate
  • Magnesium Stearate
  • Polyethylene Glycol 400
  • Titanium Dioxide
  • Triacetin
  • Cellulose, Microcrystalline
  • Fd&c Blue No. 2

Related Products:

Based on records with the same trade name.
  • 55111-619 Eszopiclone 2 mg Oral Tablet, Coated by Dr. Reddy's Laboratories Limited
  • 55111-629 Eszopiclone 1 mg Oral Tablet, Coated by Dr. Reddy's Laboratories Limited
  • 0054-0290 Eszopiclone 1 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0054-0291 Eszopiclone 2 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0054-0292 Eszopiclone 3 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0093-5537 Eszopiclone 1 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0093-5538 Eszopiclone 2 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0093-5539 Eszopiclone 3 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0378-5270 Eszopiclone 1 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-5271 Eszopiclone 2 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-5272 Eszopiclone 3 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 33342-299 Eszopiclone 1 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-300 Eszopiclone 2 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-301 Eszopiclone 3 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 42043-320 Eszopiclone 1 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 42043-321 Eszopiclone 2 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 42043-322 Eszopiclone 3 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 42291-271 Eszopiclone 1 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 42291-272 Eszopiclone 2 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 42291-273 Eszopiclone 3 mg Oral Tablet, Film Coated by Avkare, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55111-617 QR Code

< Prev: 55111-615Next: 55111-619 >

Related Discussions:

Eszopiclone (lunesta) Orange Tablets, no imprints
Small orange/peach round, uncoated pill from INDIA. No markings. They are supposed to be eszopisclone (generic lunesta).... 2 replies
Eszopiclone for old man (87 years old)
My father (87 years old) was consuming clonazepam for long time for sleep, around 1 year, and I think now he is resistan...
Side effects of eszopiclone manufactured by roxane
Are the side effects more common with the manufacturer Roxane versus Teva for the drug eszopiclone? ## No, it is still t... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.